CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


We found 8 result(s)

Brain Electrical Activity Mapping for Diagnosing Psychiatric Disorders: A Review of the Clinical Evidence

Last Updated: November 4, 2014
Result type: Reports
Product Line: Rapid Response
Research Type: Other Diagnostics

Report in Brief Context
Psychiatric disorders are thought to result from imbalances of certain neurotransmitters, or chemicals in the brain. For example, Alzheimer disease may be associated with a lack of acetylcholine, serotonin, and gamma-aminobutyric acid (GABA), while psychoses such as schizophrenia...

  • Project Number: RC0601-000

Novel antipsychotics for patients with bipolar disorder: A systematic review

Last Updated: August 15, 2001
Result type: Reports

Cite as: Shukla VK, McAuley L. Novel antipsychotics in patients with bipolar disorder: a systematic review. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2001. Technology report no 16. Objectives The purpose of this assessment is to assess the efficacy of the novel antipsychotic drugs (olanzapine, risperidone,...